These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39152752)

  • 1. Gastrointestinal disorders in systemic sclerosis: cluster analysis and prognosis from a French prospective cohort.
    Mollière C; Guédon AF; Kapel N; de Vassoigne F; Graiess F; Senet P; Cacciatore C; McAvoy C; Fain O; Rivière S; Mekinian A
    Clin Exp Rheumatol; 2024 Aug; 42(8):1656-1664. PubMed ID: 39152752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring response in the gastrointestinal tract in systemic sclerosis.
    Khanna D; Nagaraja V; Gladue H; Chey W; Pimentel M; Frech T
    Curr Opin Rheumatol; 2013 Nov; 25(6):700-6. PubMed ID: 24047604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal involvement in systemic sclerosis: An updated review.
    Nassar M; Ghernautan V; Nso N; Nyabera A; Castillo FC; Tu W; Medina L; Ciobanu C; Alfishawy M; Rizzo V; Eskaros S; Mahdi M; Khalifa M; El-Kassas M
    Medicine (Baltimore); 2022 Nov; 101(45):e31780. PubMed ID: 36397401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K; Csuka ME; Almagro UA; Soergel KH
    Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal involvement in systemic sclerosis].
    Marie I
    Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
    Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
    Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastrointestinal tract involvement in systemic sclerosis].
    Renaud A; Jirka A; Durant C; Connault J; Espitia O; Takoudju C; Agard C
    Rev Med Interne; 2023 Aug; 44(8):410-422. PubMed ID: 37270380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional status and gastrointestinal symptoms in systemic sclerosis patients.
    Murtaugh MA; Frech TM
    Clin Nutr; 2013 Feb; 32(1):130-5. PubMed ID: 22770637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry.
    Luciano L; Granel B; Bernit E; Harle JR; Baumstarck K; Grimaud JC; Bouvier M; Vitton V
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):63-69. PubMed ID: 27243115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity and impact of digestive impairment perceived by patients with systemic sclerosis: a cross-sectional study.
    Cano-García L; Redondo-Rodríguez R; Mena-Vázquez N; Manrique-Arija S; García-Studer A; Ortiz-Marquez F; Borregón-Garrido P; Fernández-Nebro A
    BMJ Open; 2024 Apr; 14(4):e083419. PubMed ID: 38684244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis.
    Yang H; Xu D; Li MT; Yao Y; Jin M; Zeng XF; Qian JM
    J Dig Dis; 2019 May; 20(5):256-261. PubMed ID: 30838807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation.
    Luebker S; Frech TM; Assassi S; Gordon JK; Bernstein EJ; Steen VD; Shah AA; Hummers LK; Richardson C; Khanna D; Castelino FV; Chung L; Hant FN; Shanmugam VK; VanBuren JM; Alvey J; Harding M; Sandorfi N
    Clin Exp Rheumatol; 2023 Aug; 41(8):1632-1638. PubMed ID: 37497718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
    Stamm L; Garaiman A; Becker MO; Bruni C; Dobrota R; Elhai M; Ismail S; Jordan S; Zampatti N; Tatu AM; Distler O; Mihai C
    RMD Open; 2024 Jul; 10(3):. PubMed ID: 39053950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis.
    Rosato E; Gigante A; Pellicano C; Villa A; Iannazzo F; Alunni Fegatelli D; Muscaritoli M
    Clin Rheumatol; 2022 Jun; 41(6):1687-1696. PubMed ID: 35149929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic Sclerosis.
    Ross L; Proudman S; Walker J; Stevens W; Ferdowsi N; Quinlivan A; Morrisroe K; Baron M; Nikpour M
    J Rheumatol; 2023 Apr; 50(4):519-525. PubMed ID: 36379565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis.
    Gualtierotti R; Ingegnoli F; Two R; Meroni PL; Khanna D; Adorni G; Becciolini A; Ciavarella T; Marfia G; Murgo A; Scalone L; Ughi N; Zeni S;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S55-60. PubMed ID: 26339890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal symptom severity and progression in systemic sclerosis.
    van Leeuwen NM; Boonstra M; Fretheim H; Brunborg C; Midtvedt Ø; Garen T; Molberg Ø; Huizinga TWJ; de Vries-Bouwstra JK; Hoffman-Vold AM
    Rheumatology (Oxford); 2022 Oct; 61(10):4024-4034. PubMed ID: 35238377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrointestinal features in systemic sclerosis].
    Stelle M; Chizzolini C
    Rev Med Suisse; 2014 Apr; 10(426):860-3. PubMed ID: 24834644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.
    Meijs J; Pors D; Vliet Vlieland TP; Huizinga TW; Schouffoer AA
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-41-8. PubMed ID: 24984228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.
    Zekovic A; Damjanov N
    Rheumatol Int; 2017 May; 37(5):735-741. PubMed ID: 28271157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.